TheProfitWatch

CRVO - CervoMed Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.04 -0.22 (-2.49%) --- -0.04 (-0.45%) -0.09 (-1.01%) --- -0.22 (-2.49%) -0.22 (-2.37%) -0.22 (-2.37%)

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.7
Diluted EPS:
Basic P/E:
-12.5929
Diluted P/E:
RSI(14) 1m:
26.64
VWAP:
8.82
RVol:

Events

Period Kind Movement Occurred At

Related News